{
    "organizations": [],
    "uuid": "435b5fcf37d038d69ab1856596d3dca4f48c7ecb",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-nanhua-bio-medicine-signs-mou-on-s/brief-nanhua-bio-medicine-signs-mou-on-scientific-research-on-hereditary-diseases-and-cell-immunotherapy-idUSL4N1PK2TZ",
    "ord_in_thread": 0,
    "title": "BRIEF-NanHua Bio-medicine signs MoU on scientific research on hereditary diseases and cell immunotherapy",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 25 (Reuters) - NanHua Bio-medicine Co Ltd :\n* Says it signs MoU with two Hunan-based bio-tech companies regarding scientific research on hereditary diseases and cell immunotherapy\nSource text in Chinese: goo.gl/UJnU3k\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-01-25T15:30:00.000+02:00",
    "crawled": "2018-01-26T21:22:46.018+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "nanhua",
        "co",
        "ltd",
        "say",
        "sign",
        "mou",
        "two",
        "company",
        "regarding",
        "scientific",
        "research",
        "hereditary",
        "disease",
        "cell",
        "immunotherapy",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}